Table 4

Frequency of HIV/AIDS patients changing ART regimens within 3, 6 or 12 months post-initiation of treatment
Gene ARV regimen or Genotype Treatment initiation (n) 3 months 6 months 12 months
ARV regimen
3TC_TDF_EFV 9 0.11 0.11 0.22
AZT_3TC_EFV 11 0.00 0.09 0.27
d4T_3TC_EFV 222 0.03 0.08 0.22
NR1I2
rs3732356T/T 156 0.04 0.11 0.24
rs3732356T/G 117 0.03 0.06 0.21
rs3732356G/G 9 0.00 0.00 0.00*
rs2472677C/C 92 0.05 0.06 0.22
rs2472677C/T 128 0.02 0.11 0.23
rs2472677T/T 36 0.03 0.11 0.17
rs6785049G/G 251 0.03 0.08 0.22
rs6785049G/A 14 0.00 0.07 0.29
NR1I3
rs2307424C/C 257 0.02 0.07 0.21
rs2307424C/T 25 0.12 0.20 0.32
rs3003596T/T 96 0.04 0.08 0.23
rs3003596T/C 132 0.03 0.10 0.20
rs3003596C/C 52 0.02 0.06 0.23
rs2502815C/C 169 0.02 0.09 0.22
rs2502815C/T 98 0.05 0.08 0.22
rs2502815T/T 15 0.00 0.00 0.20

*None of the subjects carrying the NR1I2 rs3732356G/G genotype changed their treatment regimen.

Swart et al.

Swart et al. BMC Medical Genetics 2012 13:112   doi:10.1186/1471-2350-13-112

Open Data